NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

Woodline Partners LP's Holding History (CIK: 0001784547)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 751,270 Value ($000) $26,355 Avg Close $36.39 Range $28.19 - $42.00

Q3 2025

Shares 1,157,867 Value ($000) $32,930 Avg Close $23.97 Range $17.97 - $28.91

Q2 2025

Shares 1,897,197 Value ($000) $34,358 Avg Close $18.24 Range $14.06 - $22.25

Q1 2025

Shares 2,442,397 Value ($000) $49,996 Avg Close $22.23 Range $17.18 - $26.80

Q4 2024

Shares 2,430,782 Value ($000) $62,471 Avg Close $21.24 Range $15.51 - $27.29

Q3 2024

Shares 1,164,677 Value ($000) $19,334 Avg Close $17.30 Range $15.19 - $21.48

Q2 2024

Shares 483,388 Value ($000) $9,286 Avg Close $20.06 Range $16.62 - $24.79

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	751,270	$26,355	$36.39	$28.19 - $42.00
Q3 2025	1,157,867	$32,930	$23.97	$17.97 - $28.91
Q2 2025	1,897,197	$34,358	$18.24	$14.06 - $22.25
Q1 2025	2,442,397	$49,996	$22.23	$17.18 - $26.80
Q4 2024	2,430,782	$62,471	$21.24	$15.51 - $27.29
Q3 2024	1,164,677	$19,334	$17.30	$15.19 - $21.48
Q2 2024	483,388	$9,286	$20.06	$16.62 - $24.79